reports research support for trial leadership from American Regent, Applied Therapeutics, Bayer, Cytokinetics, Merck and Novo Nordisk
Its exciting that we have medications that can help people who have obesity-related health conditions to lose weight and improve their health, but we still dont know all the ways in which they work. These results are important because they add to the growing body of evidence that GLP-1 medications work in a variety of ways to target the underlying causes of obesity, including taste perception, she notes
Industry observers note that, despite being a latecomer, Roche is emerging as a game-changer in the obesity drug market by securing a pipeline that includes both injectable and oral formulations
These risks are likely to be heightened when prescribing occurs without the structured oversight, psychological assessment and monitoring that are essential for safe use
with max percentage
Los complementos alimenticios no deben usarse como sustitutos de una dieta equilibrada ni de un modo de vida sano